Since 2013, iDSI has been working with the Indonesian government to build critical local capacity that will generate and use HTA evidence across public health and hospital care. Early impact has included policy changes around off-license prescribing and kidney dialysis. We have an ongoing collaboration to develop Indonesia’s institutional roadmap and national standards for HTA. This will help the government realise its ambition to provide sustainable UHC to all citizens by 2019 and facilitate its transition from development aid. We have conducted several workshops, visits and study tours to share technical and process expertise.
Who we work with
iDSI partners, HITAP and GHD, have been working with the Indonesia Health Technology Assessment Committee at the Ministry of Health (PPJK) and the national health insurer (JKN). We also work with Indonesia’s social insurance administration organisation, Badan Penyelenggara Jaminan Social (BPJS) Kesehatan, PATH and the WHO Indonesia Country Office.